BIOMAT Database Logo BIOMAT Database Logo

Circulating microRNAs in cancer: diagnostic and prognostic significance. 2012

Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100730, China.

The involvement of microRNAs (miRs) in numerous pathological conditions is well established. In many kinds of cancer cells and animal models, various miRs have been shown to act as oncogenes or tumor suppressors. Recently, it was found that circulating miRs can be detected, and may be associated, with the clinicopathological features and prognosis of cancers, thus, providing potential novel diagnostic and prognostic markers for malignancies in humans. This review aims to address these issues based on recently published literature.

UI MeSH Term Description Entries
D009360 Neoplastic Cells, Circulating Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. Circulating Neoplastic Cells,Embolic Tumor Cells,Embolism, Tumor,Neoplasm Circulating Cells,Tumor Cells, Embolic,Cells, Neoplasm Circulating,Circulating Cells, Neoplasm,Circulating Tumor Cells,Cell, Circulating Neoplastic,Cell, Circulating Tumor,Cell, Embolic Tumor,Cell, Neoplasm Circulating,Cells, Circulating Neoplastic,Cells, Circulating Tumor,Cells, Embolic Tumor,Circulating Neoplastic Cell,Circulating Tumor Cell,Embolic Tumor Cell,Embolisms, Tumor,Neoplasm Circulating Cell,Neoplastic Cell, Circulating,Tumor Cell, Circulating,Tumor Cell, Embolic,Tumor Cells, Circulating,Tumor Embolism,Tumor Embolisms
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
September 2017, Cell death & disease,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.
February 2013, Journal of surgical oncology,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer.
January 2016, Current pharmaceutical design,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer.
September 2013, Cancer biology & medicine,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
July 2020, The international journal of biochemistry & cell biology,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.
January 2017, Disease markers,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review.
September 2023, Journal of gastrointestinal cancer,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer.
April 2019, Cancers,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.
January 2016, Current pharmaceutical design,
Li Zhou, and Yu-Pei Zhao, and Wen-Jing Liu, and Jie Dong, and Wei-Yun Chen, and Tai-Ping Zhang, and Ge Chen, and Hong Shu
Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
September 2015, World journal of gastroenterology,
Copied contents to your clipboard!